The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third ...

Pillar Biosciences, Inc., the leader in Decision Medicinetm, announced its participation in the 2024 Association for Molecular Pathology (AMP) Annual Meeting in Vancouver, BC, Canada. The company and ...

Other objectives of the study include evaluating additional clinically relevant outcomes, deucrictibant’s safety and tolerability ... attacks resolving completely within 24 hours. The full posters and ...

Due to the expected finish time of the engineering works, first services on Monday, November 18, will be cancelled or ...

Ohio State University has hired the New York-based real-estate firm Tishman Speyer to develop the next phase of "Carmenton" ...

PLEASANT GAP, Pa. (WTAJ) – Centre County’s Public Safety Training Center is looking at a $4 million expansion project to ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers and payers in the U.S.UK ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

Multiple Key Leadership Appointments, Including Warner Biddle as CEO, Bringing Clinical, Commercial and Strategic Expertise in Cell Therapy Continuing to Advance Broad KYSA Clinical Development ...

In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.